563 related articles for article (PubMed ID: 30207476)
21. The value of lipid metabolites 9,10-DOA and 11,12-EET in prenatal diagnosis of fetal heart defects.
Fang Y; Zhang Z; Zhao Y; Sun G; Peng M; Liu C; Yi G; Zhao K; Yang H
Clin Chim Acta; 2023 Apr; 544():117330. PubMed ID: 37037297
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis of Clostridium difficile infection using an UPLC-MS based metabolomics method.
Zhou P; Zhou N; Shao L; Li J; Liu S; Meng X; Duan J; Xiong X; Huang X; Chen Y; Fan X; Zheng Y; Ma S; Li C; Wu A
Metabolomics; 2018 Jul; 14(8):102. PubMed ID: 30830376
[TBL] [Abstract][Full Text] [Related]
23. From
Liu W; Song Q; Cao Y; Xie N; Li Z; Jiang Y; Zheng J; Tu P; Song Y; Li J
J Pharm Biomed Anal; 2019 Jan; 162():16-27. PubMed ID: 30219595
[TBL] [Abstract][Full Text] [Related]
24. Nuclear magnetic resonance-based study reveals the metabolomics profile of nasopharyngeal carcinoma.
Wang Y; Luo X; Zhang GH; Li SL
Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323073
[TBL] [Abstract][Full Text] [Related]
25. Plasma metabolomic profiling of central serous chorioretinopathy.
Xu H; Huang L; Jin E; Liang Z; Zhao M
Exp Eye Res; 2021 Feb; 203():108401. PubMed ID: 33326810
[TBL] [Abstract][Full Text] [Related]
26. Metabolomics of cerebrospinal fluid reveals prognostic biomarkers in pediatric status epilepticus.
Wang T; Li C; Ma Y; Zhou H; Du X; Li Y; Long S; Ding Y; Lu G; Chen W; Zhou Y; Yu L; Wang J; Wang Y
CNS Neurosci Ther; 2023 Dec; 29(12):3925-3934. PubMed ID: 37381696
[TBL] [Abstract][Full Text] [Related]
27. Identifying Metabolic Perturbations and Toxic Effects of
Zhang P; Wang S; He Y; Xu Y; Shi D; Yang F; Yu W; Zhu W; He L
Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31683916
[TBL] [Abstract][Full Text] [Related]
28. Metabolomics identifies metabolite biomarkers associated with acute rejection after heart transplantation in rats.
Lin F; Ou Y; Huang CZ; Lin SZ; Ye YB
Sci Rep; 2017 Nov; 7(1):15422. PubMed ID: 29133921
[TBL] [Abstract][Full Text] [Related]
29. Metabolomics analysis of serum from subjects after occupational exposure to acrylamide using UPLC-MS.
Wang SY; Yu CP; Pan YL; Zhou XR; Xin R; Wang Y; Ma WW; Gao R; Wang C; Wu YH
Mol Cell Endocrinol; 2017 Mar; 444():67-75. PubMed ID: 28163100
[TBL] [Abstract][Full Text] [Related]
30. Overlap in serum metabolic profiles between non-related diseases: Implications for LC-MS metabolomics biomarker discovery.
Lindahl A; Forshed J; Nordström A
Biochem Biophys Res Commun; 2016 Sep; 478(3):1472-7. PubMed ID: 27581198
[TBL] [Abstract][Full Text] [Related]
31. Serum Metabolomic Profiling Identifies Characterization of Non-Obstructive Azoospermic Men.
Zhang Z; Zhang Y; Liu C; Zhao M; Yang Y; Wu H; Zhang H; Lin H; Zheng L; Jiang H
Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28125052
[TBL] [Abstract][Full Text] [Related]
32. Method comparison of HPLC-ninhydrin-photometry and UHPLC-PITC-tandem mass spectrometry for serum amino acid analyses in patients with complex congenital heart disease and controls.
Michel M; Salvador C; Wiedemair V; Adam MG; Laser KT; Dubowy KO; Entenmann A; Karall D; Geiger R; Zlamy M; Scholl-Bürgi S
Metabolomics; 2020 Dec; 16(12):128. PubMed ID: 33319318
[TBL] [Abstract][Full Text] [Related]
33. Metabolomic prediction of fetal congenital heart defect in the first trimester.
Bahado-Singh RO; Ertl R; Mandal R; Bjorndahl TC; Syngelaki A; Han B; Dong E; Liu PB; Alpay-Savasan Z; Wishart DS; Nicolaides KH
Am J Obstet Gynecol; 2014 Sep; 211(3):240.e1-240.e14. PubMed ID: 24704061
[TBL] [Abstract][Full Text] [Related]
34. Breast cancer detection using targeted plasma metabolomics.
Jasbi P; Wang D; Cheng SL; Fei Q; Cui JY; Liu L; Wei Y; Raftery D; Gu H
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jan; 1105():26-37. PubMed ID: 30562627
[TBL] [Abstract][Full Text] [Related]
35. Serum metabolic profiling study of lung cancer using ultra high performance liquid chromatography/quadrupole time-of-flight mass spectrometry.
Li Y; Song X; Zhao X; Zou L; Xu G
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 966():147-53. PubMed ID: 24856296
[TBL] [Abstract][Full Text] [Related]
36. Targeted metabolomics for the quantitative measurement of 9 gut microbiota-host co-metabolites in rat serum, urine and feces by liquid chromatography-tandem mass spectrometry.
Zeng Y; Lin Y; Li L; Li Y; Zhang X; Wang M; Chen Y; Luo L; Lu B; Xie Z; Liao Q
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Mar; 1110-1111():133-143. PubMed ID: 30807966
[TBL] [Abstract][Full Text] [Related]
37. Metabolomic profiles in serum and urine uncover novel biomarkers in children with nephrotic syndrome.
Hu L; Lin L; Huang G; Xie Y; Peng Z; Liu F; Bai G; Li W; Gao L; Wang Y; Li Q; Fu H; Wang J; Sun Q; Mao J
Eur J Clin Invest; 2023 Jul; 53(7):e13978. PubMed ID: 36856027
[TBL] [Abstract][Full Text] [Related]
38. Metabolomics Toward Biomarker Discovery.
Yin P; Xu G
Methods Mol Biol; 2017; 1619():467-475. PubMed ID: 28674904
[TBL] [Abstract][Full Text] [Related]
39. Liquid Chromatography-Mass Spectrometry-Based Metabolomics of Nonhuman Primates after 4 Gy Total Body Radiation Exposure: Global Effects and Targeted Panels.
Pannkuk EL; Laiakis EC; Gill K; Jain SK; Mehta KY; Nishita D; Bujold K; Bakke J; Gahagen J; Authier S; Chang P; Fornace AJ
J Proteome Res; 2019 May; 18(5):2260-2269. PubMed ID: 30843397
[TBL] [Abstract][Full Text] [Related]
40. Use of Liquid Chromatography-Mass Spectrometry-Based Metabolomics to Identify Biomarkers of Tuberculosis.
Zhou J; Yin Y
Methods Mol Biol; 2019; 1859():241-251. PubMed ID: 30421233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]